Heron Bay Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-121,302
Closed -$3.39M 115
2024
Q2
$3.39M Sell
121,302
-14,555
-11% -$401K 0.72% 39
2024
Q1
$3.77M Buy
135,857
+113,700
+513% +$3.16M 0.8% 39
2023
Q4
$638K Sell
22,157
-1,888
-8% -$57.1K 0.15% 56
2023
Q3
$798K Sell
24,045
-90,769
-79% -$3.21M 0.21% 48
2023
Q2
$4.21M Buy
114,814
+43,683
+61% +$1.7M 1.17% 31
2023
Q1
$2.9M Buy
71,131
+57,028
+404% +$2.46M 1.13% 31
2022
Q4
$723K Sell
14,103
-207
-1% -$9.92K 0.45% 44
2022
Q3
$626K Sell
14,310
-18,048
-56% -$877K 0.43% 44
2022
Q2
$1.7M Sell
32,358
-1,001
-3% -$51K 1.03% 35
2022
Q1
$1.73M Sell
33,359
-16,931
-34% -$878K 0.85% 38
2021
Q4
$2.97M Buy
50,290
+2,701
+6% +$134K 1.46% 28
2021
Q3
$2.05M Buy
47,589
+43
+0.1% +$1.91K 1.06% 35
2021
Q2
$1.86M Buy
47,546
+1,520
+3% +$59.1K 1.03% 36
2021
Q1
$1.67M Buy
46,026
+15,781
+52% +$560K 0.99% 38
2020
Q4
$1.11M Buy
+30,245
New +$1.11M 0.72% 45

Other funds holding PFE

Heron Bay Capital Management's PFE Position: Q3 2024 in Review

Heron Bay Capital Management sold out of Pfizer (PFE) in Q3 2024, closing a stake of 121,302 shares — an estimated $3.39M sold.

Heron Bay Capital Management first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $4.21M in Q2 2023. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Heron Bay Capital Management reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Heron Bay Capital Management sold 121,302 Pfizer shares in Q3 2024, an estimated $3.39M.
  • Heron Bay Capital Management first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
  • Heron Bay Capital Management's Pfizer position peaked at $4.21M in Q2 2023.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Heron Bay Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.